1,3-Pyrrolidinedicarboxylic Acid, 4-Oxo-, 1-(1,1-Dimethylethyl) 3-Ethyl Ester

The dual-protected 4-oxopyrrolidine derivative functions as a sterically biased prochiral ketone for reductive amination, enabling scalable access to 3-aminopyrrolidine-4-carboxylates—core motifs in HIV integrase strand transfer inhibitor (INSTI) pharmacophores. In a manufacturing sequence conducted in a jacketed glass-lined reactor, the substrate (1.0 eq) is dissolved in methanolic ammonia (7 N, approx. 10 vol) and charged with 10% palladium on carbon (dry basis, 0.05 wt% relative to substrate). Hydrogenation proceeds under a steady hydrogen pressure of 3.0 bar at 25 °C for 14–18 hours with gas-entrainment stirring (Rushton turbine, 800 rpm) until off-line HPLC (C18, 210 nm) shows in situ ketone consumption ≤1% area. The crude diastereomeric mixture typically exhibits a cis/trans ratio of approximately 75:25 to 82:18 depending on catalyst water content and ammonia stoichiometry. Filtration over a PTFE membrane (0.45 μm) eliminates metal debris, and the filtrate is concentrated under reduced pressure (40 °C bath) to a pale yellow oil. The amino ester is then isolated by short-path silica gel filtration (EtOAc/hexane 1:1) to afford a single diastereomer after trituration with MTBE. Residual palladium is controlled below 10 ppm in the isolated product as mandated by ICH Q3D Option 2 for Elemental Impurities (concentration-based limits for oral drug substances). The terminal output—(±)-1-(tert-butoxycarbonyl)-3-amino-pyrrolidine-4-carboxylic acid ethyl ester—is directly coupled to heterocyclic acids via EDCI/HOBt protocols to assemble the tricyclic scaffold of clinical-stage INSTI candidates (e.g. substituted pyridopyrazine integrase inhibitors). Thermal safety: differential scanning calorimetry (DSC) of the hydrogenation mixture reveals an onset of exothermic decomposition at 178 °C (heating rate 5 K/min, ASTM E537), permitting safe scale-up within standard flammable solvent guidelines.

In solid-phase peptide synthesis (SPPS), the Boc-4-oxoproline ethyl ester is converged into a ketone-bearing proline surrogate without the need for side-chain protection. The ethyl ester is selectively cleaved under non-aqueous conditions by lithium chloride–amine complexes or, more routinely, by controlled saponification: to a solution of the ester in THF/water (4:1 v/v) at 0 °C is added aqueous lithium hydroxide (1.05 eq, 1.0 M) dropwise over 30 min. After 2 h, the reaction is quenched with saturated ammonium chloride and extracted with ethyl acetate, yielding 1-(tert-butoxycarbonyl)-4-oxopyrrolidine-3-carboxylic acid in >93% purity by qNMR. This acid is directly loaded onto 2-chlorotrityl chloride resin (loading 0.8 mmol/g) using DIEA (4 eq) in DCM for 2 h at room temperature. Following capping with methanol, the resin-bound keto-proline derivative is ready for Fmoc-strategy chain elongation. The presence of the ketone group permits on-resin oxime ligation and hydrazone formation, enabling chemoselective conjugation strategies for peptidomimetic protease inhibitors. End-use products include macrocyclic peptide analogs targeting hepatitis C NS3/4A serine protease, where the keto moiety forms a reversible covalent hemiketal with the catalytic Ser139 residue—a design motif documented in acyclic P3–P1 fragment optimizations. Compliance: residual solvents (THF, DCM) are monitored per USP <467> residual solvents method; lyophilized amino acid batches consistently fall within Class 2 residual limits (THF <720 ppm). No racemization at C-3 is observed by chiral HPLC (Chiralpak IA, hexane/EtOH 90:10).

Why Does Enolate Reactivity Dictate Regiochemical Outcomes in 3,3-Disubstituted Pyrrolidine Synthesis?

The electrophilic alkylation of 1-(tert-butoxycarbonyl)-4-oxopyrrolidine-3-carboxylic acid ethyl ester through its kinetic enolate is highly dependent on the counterion and solvent microenvironment due to competing O- versus C-alkylation pathways on the ambident nucleophile. Process development for manufacturing a selective sphingosine-1-phosphate (S1P) receptor agonist intermediate required exclusive C-3 alkylation. In a cryogenic stainless-steel reactor, lithium bis(trimethylsilyl)amide (LiHMDS, 1.15 eq, 1.0 M in THF) is added to a solution of the substrate in anhydrous THF (10 vol) at −78 °C under a dry argon atmosphere. After 45 min enolate aging, methyl iodide (1.3 eq) is introduced via syringe pump over 15 min. The mixture is held at −78 °C for 2 h, then quenched into ice-cold 10% citric acid. Following extraction and Na₂SO₄ drying, GC-MS analysis (DB-5 column, 30 m) confirms <2% O-methylation byproduct. The crude 3-methyl-4-oxopyrrolidine diester is then subjected to a Grignard addition (methylmagnesium chloride, 2.5 eq in THF, −20 to −10 °C) to install a tertiary alcohol, yielding the 3,3-disubstituted pyrrolidine core. The overall yield after flash chromatography (eluent: hexane/EtOAc 4:1) is 68–72% over two steps. This building block is further transformed via Boc removal (TFA/DCM) and reductive amination into a spirocyclic piperidine analog for a CNS-penetrant GPCR modulator. Manufacturing controls include real-time reaction calorimetry (RC1e) confirming a maximum heat flow of 45 W/kg during LiHMDS addition, well within the cooling capacity of a jacketed 100 L vessel. All batch records retain endotoxin and bioburden monitoring according to EMA guideline EMA/CHMP/CVMP/QWP/33490/2018 when the downstream intermediate enters non-sterile API production.

Access to fluorinated pyrrolidines for positron emission tomography (PET) radiochemistry frequently utilizes the 4-oxo group as a redox handle for deoxyfluorination or for building gem-difluoromethylene analogs. In one validated route to a COX-2 radioligand precursor, the ketone is first reduced to the corresponding secondary alcohol using sodium borohydride (1.5 eq) in ethanol at 5 °C with calcium chloride (1.0 eq) to suppress enolization. After workup, the 3-(ethoxycarbonyl)-4-hydroxypyrrolidine derivative is dissolved in anhydrous dichloromethane under argon and cooled to −78 °C. Diethylaminosulfur trifluoride (DAST, 1.25 eq) is added dropwise, and the solution is slowly warmed to ambient temperature over 12 h. Following bicarbonate quench, the fluoro-pyrrolidine is isolated as a mixture of epimers (de ~70%) by column chromatography. The epimeric purity is raised to >98% de by recrystallization from isopropanol/heptane. Subsequent ester hydrolysis and Boc removal (HCl/dioxane) afford the free amino-alcohol, which is then radiolabeled with [¹⁸F]fluoride under automated synthesizer control (GE TracerLab FX₂ N) for injection quality control according to Ph.Eur. monograph 1325 (Radiopharmaceutical preparations). The non-radioactive reference standard is used for HPLC co-injection identity testing. Residual DAST-derived diethylaminodifluorosulfinium impurities are cleared to below 0.15% (TOF-MS single ion monitoring). The final PET tracer enables in vivo imaging of neuroinflammation in preclinical rodent models, and the intermediate remains governed by Good Manufacturing Practice (cGMP) Part 211 for the manufacturing of radiopharmaceutical cold kits.

Thermal Fragility and Boc-Deprotection Profiles in Continuous Flow Hydrogenation

Removal of the tert-butyl carbamate protective group from 1-(tert-butoxycarbonyl)-4-oxopyrrolidine-3-carboxylic acid ethyl ester in a scaled continuous flow paradigm addresses the acute exothermic hazard associated with batch acidolysis and eliminates prolonged exposure of the acid-labile ethyl ester to hydrolytic media. The substrate (neat oil) and a solution of anhydrous hydrogen chloride in ethyl acetate (3.0 M, 2.5 eq HCl) are mixed via a T-junction (0.5 mm ID) and passed through a perfluoroalkoxy (PFA) coil reactor (internal volume 10 mL) immersed in a thermostated bath at 45 °C. Using a back-pressure regulator set to 5.0 bar, a residence time of 120 seconds is maintained, achieving full conversion by inline FTIR (C=O shift at 1790 cm⁻¹ to 1745 cm⁻¹). The effluent is quenched in-line into cold heptane, and the precipitated 4-oxopyrrolidine-3-carboxylic acid ethyl ester hydrochloride salt is collected by continuous filtration on a rotary drum filter. The hydrochloride salt exhibits a melt onset of 162–165 °C and is dried under vacuum (50 °C, 10 mbar) to Karl Fischer moisture <0.5%. This immediate intermediate is thereafter protected as the N-acetyl derivative for further processing in a histamine H3 receptor antagonist development program. Process safety: the chloride ion content is monitored to ensure corrosion resistance of 316L stainless steel components, and the waste stream is neutralized using aqueous sodium bicarbonate to pH 6.5–7.5 before discharge per ISO 14001 environmental management system compliance. Occupational exposure limits (OEL) for aerosolized hydrochloride salt are maintained below 0.3 mg/m³ (8-h TWA) via engineering controls.

Within the agrochemical sector, the 4-oxopyrrolidine diester functions as a pseudo-enamine synthon for constructing pyrrolidine-fused heterocycles exhibiting acaricidal and insecticidal activity. A patent-defined synthesis of a ryanodine receptor modulator analog involves a Hantzsch-type cyclization with thiobenzamide. The 1-Boc-3-ester is first converted to the corresponding thioester via transesterification with thiophenol under titanium tetraisopropoxide catalysis (0.2 eq, toluene, reflux, 8 h). The thiophenyl ester is then condensed with N-methylthiobenzamide and ammonium acetate in glacial acetic acid to yield a thiazole-fused pyrrolidine. Following Boc-group removal with formic acid (96%, 8 h), the secondary amine is sulfonylated with 4-chlorobenzenesulfonyl chloride (1.1 eq) in pyridine to generate the lead candidate. The ethyl ester is reserved until the final step, where LiAlH₄ reduction (1.0 eq in THF, −5 °C) liberates a hydroxymethyl group, which is immediately oxidized to the aldehyde via Dess-Martin periodinane (1.5 eq) for subsequent aldol condensation. Formulated as a suspension concentrate (SC) for field trials, the molecule meets the CIPAC (Collaborative International Pesticides Analytical Council) MT 46.3 flowability criterion. The non-Boc intermediate is also evaluated for eco-toxicological endpoints per US EPA 40 CFR Part 158 (Daphnia magna acute immobilization test, OECD 202). Residual titanium from the transesterification step is controlled below 25 ppm via a silica-gel pad filtration to meet the 0.1 mg/kg plant-back restriction for rotational crops.